Today, the American Kidney Fund (AKF) and the IgA Nephropathy Foundation are on Capitol Hill with more than 80 advocates who are living with rare kidney diseases to urge elected officials to support ...

On Dec. 1, Travere Therapeutics will have a new CEO for the first time in almost eight years, as Eric Dube hands the baton to ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.

Novartis gained approval of a drug in IgAN with the same target as Roche’s sefaxersen in 2026.

Discover why Travere Therapeutics Inc's stock is sliding today, with insights into its recent patent news and leadership ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The US Food and Drug Administration (FDA) has approved Mirum Pharmaceuticals’ Atebrioz (zilurgisertib) tablets to reduce the ...

Discover the latest updates on Baytex Energy Corp stock, including performance metrics, analyst outlooks, and key company ...

Travere Therapeutics, Inc.: Cours de bourse, graphiques, cotations, conseils boursiers, données financières, analyses et ...